Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: bigg e who wrote (9207)	6/5/1998 1:59:00 AM
From: Mkilloran	Read Replies (3) \| Respond to of 23519

bigg e........thanks for the detail .....the new plant approval will reduce cost for VVUS and this will make an additional $3.00 on each unit of Muse....... Est of $14 mill in international sales in the 4th qtr is only 2 million units......What if Vivus is approved quicker in additional countries????? The new plant has capacity to produce 6-8 million units per qtr..... What is your est of US sales per qtr?????? Any est on distribution rights to Japan???? Additional milestone payments this year???